Luyan Pharma Co.,Ltd. (002788.SZ)
CNY 8.03
(-0.5%)
CNY 8.03
(-0.5%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.57 Billion CNY | 1.0% |
| 2022 | 2.54 Billion CNY | 12.03% |
| 2021 | 2.27 Billion CNY | 12.17% |
| 2020 | 2.02 Billion CNY | 15.32% |
| 2019 | 1.75 Billion CNY | 36.26% |
| 2018 | 1.29 Billion CNY | 20.89% |
| 2017 | 1.06 Billion CNY | 42.79% |
| 2016 | 747.76 Million CNY | 31.12% |
| 2015 | 570.31 Million CNY | 7.82% |
| 2014 | 528.96 Million CNY | 12.46% |
| 2013 | 470.37 Million CNY | 10.48% |
| 2012 | 425.77 Million CNY | 91.56% |
| 2011 | 222.26 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 2.44 Billion CNY | -3.22% |
| 2024 Q3 | 2.73 Billion CNY | 11.67% |
| 2024 Q1 | 2.52 Billion CNY | -1.77% |
| 2023 Q3 | 2.25 Billion CNY | -1.38% |
| 2023 Q4 | 2.57 Billion CNY | 14.06% |
| 2023 FY | 2.57 Billion CNY | 1.0% |
| 2023 Q1 | 2.38 Billion CNY | -6.45% |
| 2023 Q2 | 2.28 Billion CNY | -4.01% |
| 2022 Q4 | 2.54 Billion CNY | 9.46% |
| 2022 Q3 | 2.32 Billion CNY | 4.42% |
| 2022 Q2 | 2.22 Billion CNY | 0.49% |
| 2022 Q1 | 2.21 Billion CNY | -2.47% |
| 2022 FY | 2.54 Billion CNY | 12.03% |
| 2021 Q1 | 2.03 Billion CNY | 0.3% |
| 2021 Q2 | 2.02 Billion CNY | -0.46% |
| 2021 Q3 | 2.2 Billion CNY | 8.91% |
| 2021 Q4 | 2.27 Billion CNY | 3.17% |
| 2021 FY | 2.27 Billion CNY | 12.17% |
| 2020 Q4 | 2.02 Billion CNY | 11.16% |
| 2020 Q1 | 1.8 Billion CNY | 2.9% |
| 2020 Q2 | 1.75 Billion CNY | -2.81% |
| 2020 FY | 2.02 Billion CNY | 15.32% |
| 2020 Q3 | 1.82 Billion CNY | 3.74% |
| 2019 Q4 | 1.75 Billion CNY | 7.79% |
| 2019 FY | 1.75 Billion CNY | 36.26% |
| 2019 Q3 | 1.63 Billion CNY | 6.41% |
| 2019 Q2 | 1.53 Billion CNY | 1.77% |
| 2019 Q1 | 1.5 Billion CNY | 16.73% |
| 2018 FY | 1.29 Billion CNY | 20.89% |
| 2018 Q1 | 1.18 Billion CNY | 11.32% |
| 2018 Q2 | 1.16 Billion CNY | -2.24% |
| 2018 Q3 | 1.29 Billion CNY | 11.22% |
| 2018 Q4 | 1.29 Billion CNY | -0.13% |
| 2017 Q1 | 775.87 Million CNY | 3.76% |
| 2017 Q2 | 1.06 Billion CNY | 37.68% |
| 2017 FY | 1.06 Billion CNY | 42.79% |
| 2017 Q4 | 1.06 Billion CNY | -7.96% |
| 2017 Q3 | 1.16 Billion CNY | 8.6% |
| 2016 Q4 | 747.76 Million CNY | -19.52% |
| 2016 Q3 | 929.18 Million CNY | -2.39% |
| 2016 Q2 | 951.88 Million CNY | 22.53% |
| 2016 Q1 | 776.87 Million CNY | 36.22% |
| 2016 FY | 747.76 Million CNY | 31.12% |
| 2015 Q3 | 573.48 Million CNY | 0.0% |
| 2015 Q4 | 570.31 Million CNY | -0.55% |
| 2015 FY | 570.31 Million CNY | 7.82% |
| 2015 Q1 | - CNY | 0.0% |
| 2014 FY | 528.96 Million CNY | 12.46% |
| 2013 FY | 470.37 Million CNY | 10.48% |
| 2012 FY | 425.77 Million CNY | 91.56% |
| 2011 FY | 222.26 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 2.56 Billion CNY | -0.483% |
| Yixintang Pharmaceutical Group Co., Ltd. | 3.85 Billion CNY | 33.185% |
| ZJAMP Group Co., Ltd. | 5.96 Billion CNY | 56.823% |
| Ji Yao Holding Group Co., Ltd. | 116.44 Million CNY | -2110.641% |